Cafepharma Today

October 24 2024 - Weight-loss drugs didn't curb health costs within two years
Weight-loss drugs didn't curb health costs within two years
GSK answers Pfizer's RSV approval with data targeting matching nod in younger adults
Why pharma megamergers may become a relic of the past
Lundbeck planning for four novel drugs in phase 3 in 2026
*please scroll down for all the latest news*

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

*please scroll down for all the latest news*

Current News

submit a press release

Genzyme, PTC Therapeutics Cystic Fibrosis Drug Relieves Symptom
Bloomberg
Thursday, August 21, 2008 - 12:07pm
tags:
Bristol-Myers Ponies Up for Elotuzumab
Seeking Alpha
Thursday, August 21, 2008 - 12:06pm
tags:
Why I'm Buying Amylin Now
Seeking Alpha
Thursday, August 21, 2008 - 12:05pm
tags:
GlaxoSmithKline to Disclose Grants to Hospitals, Patient Groups
WSJ Online
Thursday, August 21, 2008 - 12:04pm
tags:
Lilly releases more favorable study results for cardio drug prasugrel, which awaits FDA OK
Yahoo/AP
Thursday, August 21, 2008 - 12:03pm
tags:
Abbott streamlining plan to save more than $150 mln a year
Marketwatch
Thursday, August 21, 2008 - 12:02pm
tags:
Alpharma Hurt by Medco as Insurers Balk at Pain Patch
Bloomberg
Thursday, August 21, 2008 - 12:00pm
tags:
P&G to License Noven's Patch for Women's Sex Drive
Bloomberg
Thursday, August 21, 2008 - 11:59am
tags:
Merck Cancer Shot May Not Be Economical for All Women
Bloomberg
Thursday, August 21, 2008 - 11:58am
tags:
Eli Lilly reports statistically superior results from Phase III head-to-head TRITON-TIMI 38 study - Quick Facts
RTT News
Thursday, August 21, 2008 - 11:56am
tags:
Bayer and Onyx Begin Enrollment in STORM Trial Studying Nexavar as Adjuvant Therapy for Patients With Liver Cancer
Yahoo
Thursday, August 21, 2008 - 11:55am
tags:
FDA asks Johnson & Johnson for more information on Doribax
Marketwatch
Thursday, August 21, 2008 - 9:59am
tags:
Regeneron reports encouraging data from Phase II AMD trial
Pharmaceutical Business Review
Thursday, August 21, 2008 - 9:54am
tags:
AstraZeneca can claim compensation over copycat Prilosec
Pharma Times, UK
Thursday, August 21, 2008 - 9:52am
tags:
Perrigo Picks Up On Profit
Seeking Alpha
Thursday, August 21, 2008 - 9:44am
tags:
Tough Projections for Big Pharmas: Drug Revenues Don't Look Promising
Seeking Alpha
Thursday, August 21, 2008 - 9:41am
tags:
Cypress Bioscience: About To Reverse Course?
Seeking Alpha
Thursday, August 21, 2008 - 9:40am
tags:
Former Vioxx patients will soon receive suit payments
Daily Record, NJ
Thursday, August 21, 2008 - 9:39am
tags:

Pages

Latest CP Wire Articles

Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies
Sapio Sciences launches new drug discovery platform
Bristol Myers Squibb Strengthens and Diversifies Oncology Portfolio With Acquisition of Mirati Therapeutics
Why Medical and Pharma Sales Reps Should Start Their Own Senior Care Business
Bend Bioscience Adds Capacity and Technology Offerings with the Addition of New Process and Manufacturing Science Facility

Latest Pharmagather Articles

A Pfight at Pfizer
In the Pipeline
Clinical Trial Volunteers, And Others
In the Pipeline
The 340B Program Reached $66 Billion in 2023—Up 23% vs. 2022: Analyzing the Numbers and HRSA’s Curious Actions
Drug Channels
HCN in Acetonitrile, You Say?
In the Pipeline
Informa Connect’s Trade and Channel Strategies
Drug Channels
AI Does Not Make It Easy
In the Pipeline
The Promise of a Direct-to-Patient Model—Breaking Down What’s Really Needed for Better Patient Access
Drug Channels
Accelerated Approval: What Is It Accomplishing?
In the Pipeline
Cleaning up "Scientific Reports": Can It Be Done?
In the Pipeline

Latest Jobs

Account Manager-Orlando, FL-Ophthalmics
Maitland, Florida, 32794
Sun Pharmaceutical Industries, Inc.
Account Manager-Orlando, FL-Ophthalmics
Alafaya, Florida
Sun Pharmaceutical Industries, Inc.
Account Manager-Orlando, FL-Ophthalmics
Union Park, Florida
Sun Pharmaceutical Industries, Inc.
Account Manager-Houston West-Ophthalmics
Bunker Hill Village, Texas
Sun Pharmaceutical Industries, Inc.
Account Manager-Phoenix, AZ-Oncology
Paradise Valley, Arizona, 85253
Sun Pharmaceutical Industries, Inc.
Account Manager-Houston West-Ophthalmics
Pasadena, Texas, 77505
Sun Pharmaceutical Industries, Inc.
Account Manager-Houston West-Ophthalmics
Cloverleaf, Texas
Sun Pharmaceutical Industries, Inc.
Account Manager-Orlando, FL-Ophthalmics
Gotha, Florida, 34734
Sun Pharmaceutical Industries, Inc.
Account Manager-Orlando, FL-Ophthalmics
Longwood, Florida, 32791
Sun Pharmaceutical Industries, Inc.
Territory Manager - Medical Dermatology, Richmond VA
Richmond
Sun Pharmaceutical Industries, Inc.
more jobs

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.

Do Not Allow Advertisers to Use My Personal information